Spring-loaded model revisited: Paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein

Journal of Virology

Volumn 85, Issue 24, 2011, Pages 12867-12880

  Porotto, Matteo ^a   De Vito, Ilaria ^a   Palmer, Samantha G ^a   Jurgens, Eric M ^a   Yee, Jia L ^a   Yokoyama, Christine C ^a   Pessi, Antonello ^b   Moscona, Anne ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b PeptiPharma   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ NEURAMINIDASE; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CONFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; VIRUS ACTIVATION; VIRUS ENTRY;

CELL LINE; HN PROTEIN; HUMANS; MODELS, BIOLOGICAL; NIPAH VIRUS; PARAINFLUENZA VIRUS 3, HUMAN; PROTEIN BINDING; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION;

HUMAN PARAINFLUENZA VIRUS 3; NIPAH VIRUS; PARAMYXOVIRIDAE;

EID: 84855270854     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05873-11     Document Type: Article

References (82)

1. Aguilar, H. C., V. Aspericueta, L. R. Robinson, K. E. Aanensen, and B. Lee. 2010. A quantitative and kinetic fusion protein-triggering assay can discern distinct steps in the Nipah virus membrane fusion cascade. J. Virol. 84:8033-8041.
2. Aguilar, H. C., et al. 2006. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J. Virol. 80:4878-4889.
3. Amberg, S. M., R. C. Netter, G. Simmons, and P. Bates. 2006. Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide. J. Virol. 80:353-359.
4. Atanasiu, D., et al. 2007. Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion. Proc. Natl. Acad. Sci. U. S. A. 104:18718-18723.
5. Baker, K. A., R. E. Dutch, R. A. Lamb, and T. S. Jardetzky. 1999. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell 3:309-319.
6. Bishop, K. A., et al. 2008. Residues in the stalk domain of the Hendra virus g glycoprotein modulate conformational changes associated with receptor binding. J. Virol. 82:11398-11409.
7. Carr, C. M., C. Chaudhry, and P. S. Kim. 1997. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc. Natl. Acad. Sci. U. S. A. 94:14306-14313.
8. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832.
9. Chaiwatpongsakorn, S., R. F. Epand, P. L. Collins, R. M. Epand, and M. E. Peeples. 2011. Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer. J. Virol. 85:3968-3977.
10. Connolly, S. A., G. P. Leser, T. S. Jardetzky, and R. A. Lamb. 2009. Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J. Virol. 83:10857-10868.
11. Connolly, S. A., G. P. Leser, H. S. Yin, T. S. Jardetzky, and R. A. Lamb. 2006. Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc. Natl. Acad. Sci. U. S. A. 103:17903-17908.
12. Corey, E. A., and R. M. Iorio. 2007. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virusspecific interaction with the homologous fusion protein. J. Virol. 81:9900-9910.
13. Delos, S. E., J. A. Godby, and J. M. White. 2005. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation. J. Virol. 79:3488-3499.
14. Dutch, R. E. 2010. Entry and fusion of emerging paramyxoviruses. PLoS Pathog. 6:e1000881.
15. Earp, L. J., S. E. Delos, H. E. Park, and J. M. White. 2005. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285:25-66.
16. Eckert, D. M., and P. S. Kim. 2001. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:777-810.
17. Ekiert, D. C., et al. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
18. Farzan, S., et al. 2011. Premature activation of the paramyxovirus fusion protein before target cell attachment: corruption of the viral fusion machinery. J. Biol. Chem. [Epub ahead of print.] doi:10.1074/jbc.M111.256248.
19. Fletcher, C. V. 2003. Enfuvirtide, a new drug for HIV infection. Lancet 361:1577-1578.
20. Fredericksen, B. L., and M. A. Whitt. 1996. Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion. Virology 217:49-57.
21. Gilbert, J. M., L. D. Hernandez, J. W. Balliet, P. Bates, and J. M. White. 1995. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:7410-7415.
22. Greengard, O., N. Poltoratskaia, E. Leikina, J. Zimmerberg, and A. Moscona. 2000. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J. Virol. 74:11108-11114.
23. Harrison, S. C. 2008. Viral membrane fusion. Nat. Struct. Mol. Biol. 15:690-698.
24. Hoffman, L. R., I. D. Kuntz, and J. M. White. 1997. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. J. Virol. 71:8808-8820.
25. Horga, M. A., et al. 2000. Mechanism of interference mediated by human parainfluenza virus type 3 infection. J. Virol. 74:11792-11799.
26. Hu, C. D., Y. Chinenov, and T. K. Kerppola. 2002. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9:789-798.
27. Hu, C. D., and T. K. Kerppola. 2003. Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat. Biotechnol. 21:539-545.
28. Ingallinella, P., et al. 2009. Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency. Proc. Natl. Acad. Sci. U. S. A. 106:5801-5806.
29. Iorio, R. M., V. R. Melanson, and P. J. Mahon. 2009. Glycoprotein interactions in paramyxovirus fusion. Future Virol. 4:335-351.
30. Lamb, R. A., R. G. Paterson, and T. S. Jardetzky. 2006. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344:30-37.
31. Lambert, D. M., et al. 1996. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. U. S. A. 93:2186-2191.
32. Lee, B., and Z. A. Ataman. 2011. Modes of paramyxovirus fusion: a henipavirus perspective. Trends Microbiol. 19:389-399.
33. Li, J., V. R. Melanson, A. M. Mirza, and R. M. Iorio. 2005. Decreased dependence on receptor recognition for the fusion promotion activity of L289A-mutated Newcastle disease virus fusion protein correlates with a monoclonal antibody-detected conformational change. J. Virol. 79:1180-1190.
34. Li, J., E. Quinlan, A. Mirza, and R. M. Iorio. 2004. Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion. J. Virol. 78:5299-5310.
35. Lin, H. P., C. Vincenz, K. W. Eliceiri, T. K. Kerppola, and B. M. Ogle. 2010. Bimolecular fluorescence complementation analysis of eukaryotic fusion products. Biol. Cell 102:525-537.
36. Lu, M., S. C. Blacklow, and P. S. Kim. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1075-1082.
37. Ludwig, K., et al. 2008. Electron cryomicroscopy reveals different F1+F2 protein states in intact parainfluenza virions. J. Virol. 82:3775-3781.
38. Mahon, P. J., A. M. Mirza, and R. M. Iorio. 2011. Role of the two sialic acid binding sites on the NDV HN protein in triggering the interaction with the F protein required for the promotion of fusion. J. Virol. [Epub ahead of print.] doi:10.1128/JVI.05679-11.
39. Melanson, V. R., and R. M. Iorio. 2004. Amino acid substitutions in the F-specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J. Virol. 78:13053-13061.
40. Mirza, A. M., et al. 2011. Triggering of the Newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptors. J. Biol. Chem. 286:17851-17860.
41. Moosmann, P., and S. Rusconi. 1996. Alpha complementation of LacZ in mammalian cells. Nucleic Acids Res. 24:1171-1172.
42. Moscona, A. 2005. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J. Clin. Investig. 115:1688-1698.
43. Murrell, M., O. Greengard, M. Porotto, N. Poltoratskaia, and A. Moscona. 2001. A single amino acid alteration in the human parainfluenza virus type 3 HN confers resistance to both binding inhibition and neuraminidase inhibition by the antiviral agent 4-GU-DANA (zanamivir). J. Virol. 75:6310-6320.
44. Murrell, M., M. Porotto, T. Weber, O. Greengard, and A. Moscona. 2003. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (zanamivir). J. Virol. 77:309-317.
45. Navaratnarajah, C. K., et al. 2011. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat. Struct. Mol. Biol. 18:128-134.
46. Netter, R. C., et al. 2004. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate. J. Virol. 78:13430-13439.
47. Obrig, T. G., W. J. Culp, W. L. McKeehan, and B. Hardesty. 1971. The mechanism by which cycloheximide and related glutarimide antibiotics in-hibit peptide synthesis on reticulocyte ribosomes. J. Biol. Chem. 246:174-181.
48. Palermo, L., et al. 2009. Human parainfluenza virus infection of the airway epithelium: the viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. J. Virol. 83:6900-6908.
49. Palermo, L. M., M. Porotto, O. Greengard, and A. Moscona. 2007. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II. J. Virol. 81:9152-9161.
50. Plemper, R. K., A. L. Hammond, D. Gerlier, A. K. Fielding, and R. Cattaneo. 2002. Strength of envelope protein interaction modulates cytopathicity of measles virus. J. Virol. 76:5051-5061.
51. Porotto, M., et al. 2007. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors. J. Virol. 81:10567-10574.
52. Porotto, M., et al. 2006. Inhibition of Hendra virus membrane fusion. J. Virol. 80:9837-9849.
53. Porotto, M., et al. 2006. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site. J. Virol. 80:1204-1213.
54. Porotto, M., M. Fornabaio, G. Kellogg, and A. Moscona. 2007. A second receptor binding site on the human parainfluenza 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J. Virol. 81:3216-3228.
55. Porotto, M., O. Greengard, N. Poltoratskaia, M.-A. Horga, and A. Moscona. 2001. Human parainfluenza virus type 3 HN-receptor interaction: the effect of 4-GU-DANA on a neuraminidase-deficient variant. J. Virol. 76:7481-7488.
56. Porotto, M., M. Murrell, O. Greengard, L. Doctor, and A. Moscona. 2005. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. J. Virol. 79:2383-2392.
57. Porotto, M., et al. 2004. Inhibition of parainfluenza type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites. J. Virol. 78:13911-13919.
58. Porotto, M., M. Murrell, O. Greengard, and A. Moscona. 2003. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN): an HN mutation diminishing the rate of F activation and fusion. J. Virol. 77:3647-3654.
59. Porotto, M., et al. 2010. Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry. PLoS Pathog. 6:e1001168.
60. Porotto, M., et al. 2009. Kinetic dependence of paramyxovirus entry inhibition. J. Virol. 83:6947-6951.
61. Porotto, M., et al. 2010. Viral entry inhibitors targeted to the membrane site of action. J. Virol. 84:6760-6768.
62. Rapaport, D., M. Ovadia, and Y. Shai. 1995. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14:5524-5531.
63. Russell, C. J., T. S. Jardetzky, and R. A. Lamb. 2001. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J. 20:4024-4034.
64. Russell, C. J., K. L. Kantor, T. S. Jardetzky, and R. A. Lamb. 2003. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J. Cell Biol. 163:363-374.
65. Saphire, E. O., and M. B. Oldstone. 2011. Measles virus fusion shifts into gear. Nat. Struct. Mol. Biol. 18:115-116.
66. Sapir, A., O. Avinoam, B. Podbilewicz, and L. V. Chernomordik. 2008. Viral and developmental cell fusion mechanisms: conservation and divergence. Dev. Cell 14:11-21.
67. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
68. Shyu, Y. J., H. Liu, X. Deng, and C. D. Hu. 2006. Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques 40:61-66.
69. Skehel, J. J., et al. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 79:968-972.
70. Smith, E. C., A. Popa, A. Chang, C. Masante, and R. E. Dutch. 2009. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 276:7217-7227.
71. Sui, J., et al. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16:265-273.
72. Wang, Z., and R. M. Iorio. 1999. Amino acid substitutions in a conserved region in the stalk of the Newcastle disease virus HN glycoprotein spike impair its neuraminidase activity in the globular domain. J. Gen. Virol. 80:749-753.
73. Weissenhorn, W., A. Hinz, and Y. Gaudin. 2007. Virus membrane fusion. FEBS Lett. 581:2150-2155.
74. Wharton, S. A., J. J. Skehel, and D. C. Wiley. 2000. Temperature dependence of fusion by Sendai virus. Virology 271:71-78.
75. White, J. M., S. E. Delos, M. Brecher, and K. Schornberg. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43:189-219.
76. White, J. M., and I. A. Wilson. 1987. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J. Cell Biol. 105:2887-2896.
77. Wild, C. T., D. C. Shugars, T. K. Greenwell, C. B. McDanal, and T. J. Matthews. 1994. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. U. S. A. 91:9770-9774.
78. Xu, R., and I. A. Wilson. 2011. Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. J. Virol. 85:5172-5182.
79. Yao, Q., and R. W. Compans. 1996. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223:103-112.
80. Yin, H. S., R. G. Paterson, X. Wen, R. A. Lamb, and T. S. Jardetzky. 2005. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc. Natl. Acad. Sci. U. S. A. 102:9288-9293.
81. Yin, H. S., X. Wen, R. G. Paterson, R. A. Lamb, and T. S. Jardetzky. 2006. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439:38-44.
82. Zaitsev, V., et al. 2004. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78:3733-3741.